Latest News & Updates

Breaking News

  • 40 minutes ago

  • Pharma Now Editorial Team

Bayer Acquires Perfuse Therapeutics in $2.45 Billion Deal for Ocular Pipeline Asset PER-001
Breaking News
Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India Pharma Supply Reach

Pharma Now Editorial Team

Neuland Labs Signs Partnership with LIR Life for Transdermal GLP-1 Obesity Therapy Platform

Pharma Now Editorial Team

Roche Acquires PathAI in $750 Million Deal to Expand AI-Driven Companion Diagnostics

Pharma Now Editorial Team

Zealand Pharma Advances Petrelintide to Phase 3 After Positive ZUPREME-1 Results in Obesity Program

Pharma Now Editorial Team

Other trending news you may like to read

Bayer Acquires Perfuse Therapeutics in $2.45 Billion Deal for Ocular Pipeline Asset PER-001

Bayer acquires Perfuse Therapeutics for $2.45B, gaining Phase II ocular asset PER-001 for glaucoma and diabetic retinopathy.

Pharma Now Editorial Team

Pharma Now

Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India Pharma Supply Reach

Safic-Alcan acquires majority stake in SA Ingredients, reshaping excipient distribution across India's GMP pharma supply chain.

Pharma Now Editorial Team

Pharma Now

Neuland Labs Signs Partnership with LIR Life for Transdermal GLP-1 Obesity Therapy Platform

Neuland Labs partners with LIR Life to develop a patch-based transdermal delivery platform for GLP-1 obesity therapies.

Pharma Now Editorial Team

Pharma Now

Roche Acquires PathAI in $750 Million Deal to Expand AI-Driven Companion Diagnostics

Roche acquires PathAI for $750M upfront to integrate AI pathology tools into companion diagnostics and clinical trial workflows.

Pharma Now Editorial Team

Pharma Now